MétaCan
Menu
← Back to cohort
Record W4416085335 · doi:10.1093/neuonc/noaf201.1397

EXTH-64. Allogeneic CAR-DNT cell therapy to overcome spatial heterogeneity in glioblastoma

2025· article· en· W4416085335 on OpenAlexaff
Laura Mah, Taye Louie, José María Lamo-Espinosa, Shannon Snelling, Xueqing Lun, Michele Nawata, Ted Verhey, Varsha Thoppey Manoharan, Jennifer A. Chan, A. Sorana Morrissy, Jongbok Lee, Franz J. Zemp, Douglas J. Mahoney

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsUniversity of Calgary
FundersFonds Wetenschappelijk Onderzoek
KeywordsChimeric antigen receptorCytotoxicityCytotoxic T cellCell therapyIn vitroGlioblastomaImmunotherapyCD19AntigenCell

Abstract

fetched live from OpenAlex

Abstract Glioblastoma (GBM) is the most common primary malignant brain tumour, with a 5-year survival rate under 10%. Chimeric antigen receptor (CAR)-T cell therapy shows promise, but tumour heterogeneity – especially between the tumour core and infiltrative edge – complicates target selection. Edge cells are particularly challenging to eliminate due to their migration into healthy brain tissue. Further, the cost and complexity of manufacturing autologous CAR-T therapy limit accessibility. This study explores an innovative allogeneic CAR-T strategy capable of targeting multiple tumour subpopulations, improving the efficacy and accessibility of CAR-T treatment for GBM. We utilised double-negative T (DNT) cells (CD3+CD4-CD8-), which exhibit innate anti-tumour cytotoxic activity and are suitable for allogeneic use without inducing graft-versus-host disease (GvHD). DNTs were engineered with second-generation 4-1BB CARs targeting CD276 or CD19 (negative control). To evaluate efficacy, we developed a novel orthotopic xenograft model using human brain tumour-initiating cells (BTICs) isolated from spatially distinct tumour regions – core (X) and edge (Z). Fluorescently labelled X- and Z-BTICs were implanted intracranially at a 1:1 ratio. CAR-DNTs demonstrated CAR transduction efficiency and in vitro cytotoxicity comparable to conventional CD4+/CD8+ T (Tconv) cells. In vivo, αCD276 CAR-DNTs and CAR-Tconv cells similarly extended survival in the XZ GBM model. However, only CAR-Tconv treatment induced severe xenogeneic GvHD. Notably, all αCD276 CAR groups showed full or predominant clearance of Z-edge cells at relapse. Additionally, DNTs mediated CAR-independent cytotoxicity of X-core BTICs in vitro compared to Tconv cells. Ongoing studies are investigating whether eradication of Z-edge cells depends on the presence of X-core cells and potential inter-population crosstalk. We will also assess whether the edge-targeting capacity of αCD276 CARs with the core-targeting effects of DNTs can offer a comprehensive solution to overcome GBM spatial heterogeneity. αCD276 CAR-DNTs hold promise for a more effective, accessible, and scalable treatment paradigm for GBM, ultimately transforming patient care.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.351
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicCAR-T cell therapy research→French-language works237,207→